Healthwell Acquisition Corp. I Acquires Starton Therapeutics to Create Public Continuous Delivery Platform
April 27, 2023
Starton Therapeutics and Healthwell Acquisition Corp. I entered into a definitive business combination agreement under which a newly formed Pubco subsidiary of Healthwell will acquire Starton and become a publicly traded company. The transaction is expected to close in the second half of 2023 and is designed to commercialize Starton’s proprietary continuous delivery technology for oncology therapeutics, including programs in multiple myeloma and chronic lymphocytic leukemia.
- Buyers
- Healthwell Acquisition Corp. I, HWEL Holdings Corp. (Pubco)
- Targets
- Starton Therapeutics, Inc.
- Industry
- Biotechnology
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Westin Acquisition Corp Domestication and Merger with First Choice Healthcare Solutions to Form Wellgevity 360, Inc.
July 25, 2026
Healthcare Services
Westin Acquisition Corp. entered into a definitive merger agreement with First Choice Healthcare Solutions to create Wellgevity 360, Inc., a publicly traded healthcare and wellness platform focused on longevity, preventative care, and biology-driven treatment. The transaction is expected to close in the fourth quarter of 2026, subject to customary approvals and closing conditions, and implies a pre-money equity value for First Choice of approximately $650 million.
-
WELL Health Technologies to Acquire Majority Control of HEALWELL AI Concurrent With HEALWELL’s Acquisition of Orion Health
April 1, 2025
Healthcare Services
WELL Health Technologies plans to amend and exercise its call right to acquire a majority controlling interest in HEALWELL AI (HEALWELL) concurrent with the anticipated closing of HEALWELL’s proposed acquisition of Orion Health on April 1, 2025. Following the exercise, WELL expects to begin consolidating HEALWELL from April 1, 2025 and to hold about 37% economic interest and about 69% voting interest in HEALWELL (non-diluted). Separately, HEALWELL completed the Orion Health acquisition on April 1, 2025 and WELL exercised the call right at the same time.
-
Health & Wellness Partners Acquires Hybrid Healthcare Communications
October 6, 2023
Healthcare Services
Health & Wellness Partners (HWP), a PE-backed medical and scientific communications agency, has acquired Hybrid Healthcare Communications to combine HWP's medical content and strategic offerings with Hybrid's digital and interactive engagement capabilities. The deal expands HWP's service capabilities across medical affairs, marketing, and speaker bureau offerings and strengthens its digital and virtual engagement solutions.
-
Softheon Acquires NextHealth Technologies
June 30, 2022
Healthcare Services
Softheon has acquired NextHealth Technologies, an AI-powered SaaS healthcare analytics platform, to accelerate its AI and care-management capabilities for health plans. The deal brings NextHealth’s team and technology into Softheon and results in NextHealth investors Norwest Venture Partners and TT Capital Partners becoming investors in Softheon to support combined growth.
-
Viveon Health Acquisition Corp. to Merge with Suneva Medical
January 12, 2022
Medical Devices
Suneva Medical, a San Diego–based regenerative aesthetics medical technology company, has entered into a definitive merger agreement with special purpose acquisition company Viveon Health Acquisition Corp. The transaction will combine Suneva with the public SPAC vehicle (NYSE American: VHAQ) to provide growth capital and public-market access for Suneva, with the combined company expected to trade on the NYSE under the symbol "RNEW."
-
WELL Health Acquires ExecHealth Inc.
April 8, 2021
Healthcare Services
WELL Health Technologies Corp. agreed to acquire all issued and outstanding shares of ExecHealth Inc., an Ottawa-based omni-channel provider of primary, corporate and executive health services. The deal consideration includes CA$6.52M cash, CA$4.21M in WELL common shares and a performance-based earn-out of up to CA$1.89M; the transaction expands WELL's clinical footprint into Ontario and its premium corporate/executive health offering.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.